| Structure | Chemical Name | CAS | MF |
|
ETHYLENEDIAMINETETRAACETIC ACID TRIPOTASSIUM SALT DIHYDRATE
|
65501-24-8
|
C10H19KN2O9
|
|
Ethylenediaminetetraacetic acid trisodium salt trihydrate
|
65501-25-9
|
C10H19N2Na3O11
|
|
Hexanoic acid, 6-(benzoylamino)-, compd. with 2,2',2''-nitrilotris[ethanol]
|
65501-69-1
|
C19H32N2O6
|
|
1-OCTANESULFONAMIDE
|
65501-71-5
|
C8H19NO2S
|
|
2H-1-Benzopyran-2-one, 4-methyl-7-(beta-D-xylosyloxy)-
|
65502-34-3
|
|
|
3,3,4-trimethyl-1-pentanol
|
65502-58-1
|
C8H18O
|
|
4,4,5-trimethylhexan-1-ol
|
65502-61-6
|
C9H20O
|
|
Morpholine, 2,2,6,6-tetrafluoro- (9CI)
|
65502-95-6
|
C4H5F4NO
|
|
Poly 18 antigen
|
65503-43-7
|
C105H135N19O37
|
|
1-Piperazinamine,4-butyl-(9CI)
|
65504-31-6
|
C8H19N3
|
|
Chromate(1-), bis(7,8,9,10,11-.eta.)-1,2,3,4,5,6,9,10,11-nonahydro-7,8-dimethyl-7,8-dicarbaundecaborato(2-)-
|
65504-45-2
|
C8H12B18Cr-
|
|
1H-Pyrazole, 1-phenyl-3(or 5)-propyl-
|
65504-93-0
|
C12H14N2
|
|
2-ETHOXY-3-METHYLPYRAZINE
|
65504-94-1
|
C7H10N2O
|
|
1,4-Dioxan-2-one, 5(or 6)-butyl-
|
65504-95-2
|
|
|
1,4-Dioxan-2-one, 5(or 6)-pentyl-
|
65504-96-3
|
C9H16O3
|
|
1,4-Dioxan-2-one, 5(or 6)-hexyl-
|
65504-97-4
|
C10H18O3
|
|
disodium 4-[2-[(1-oxooctadecadienyl)amino]ethyl] 2-sulphonatosuccinate
|
65504-99-6
|
C24H40NNa2O8S
|
|
2,5-Dimethyl-3-thiofuroylfuran
|
65505-16-0
|
C11H10O3S
|
|
Methyl 2-methyl-3-furyl disulfide
|
65505-17-1
|
C6H8OS2
|
|
Thiazole, 5-ethenyl-2,4-dimethyl-
|
65505-18-2
|
C7H9NS
|
|
isobutyl 2-(methylamino)benzoate
|
65505-24-0
|
C12H17NO2
|
|
FEMA 3320
|
65505-25-1
|
C14H16O3
|
|
Imidazo[4,5,1-hi]indazole (9CI)
|
65505-39-7
|
C8H5N3
|
|
5-chloromercurio-2-'-deoxyuridine
|
65505-76-2
|
|
|
|
TRITON
|
65506-72-1
|
|
|
Maroxepin
|
65509-24-2
|
C19H19NO
|
|
Citatepine
|
65509-66-2
|
C20H18N2S
|
|
2',3,4,4',5-PENTACHLOROBIPHENYL
|
65510-44-3
|
C12H5Cl5
|
|
2,2',3,4,4'-PENTACHLOROBIPHENYL
|
65510-45-4
|
C12H5Cl5
|
|
1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14-nonacosafluoro-16-iodohexadecane
|
65510-55-6
|
C16H4F29I
|
|
1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-nonadecafluoro-11-iodoundecane
|
65510-56-7
|
C11H4F19I
|
|
TERT-BUTYL 5,7-DIMETHOXY-4-OXO-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE
|
65510-96-5
|
C14H17NO5
|
|
(-)-2,3-dihydro-5,7-dihydroxy-2-methyl-4-quinolone
|
65511-03-7
|
C10H11NO3
|
|
Nantradol
|
65511-41-3
|
C27H35NO4
|
|
Nantradol
|
65511-42-4
|
C27H36ClNO4
|
|
desacetylnantradol
|
65511-54-8
|
C25H33NO3
|
|
nandrolone 3-(o-carboxymethyl)oxime
|
65512-40-5
|
C20H29NO4
|
|
5-BroMo-6-Methylquinoline
|
65513-45-3
|
C10H8BrN
|
|
1-GLYCERYL N-[7-CHLORO-4-QUINOLYL]ANTHRANILATE HYDROCHLORIDE
|
65513-72-6
|
C19H18Cl2N2O4
|
|
(1S)-1,2,3,4,5,6,7,8-Octahydro-1-methyl-7β-(1-methylene-2-hydroxyethyl)-2β,3α-naphthalenediol
|
65513-76-0
|
C14H22O3
|
|
Clozapine EP IMpurity D
|
65514-71-8
|
C18H21ClN4O
|
|
1-[2-[(4-CHLORO-2-NITROPHENYL)AMINO]BENZOYL]-4-METHYL-PIPERAZINE
|
65514-72-9
|
C18H19ClN4O3
|
|
2-Cyclohexene-1-carbonyl chloride, 3-methyl- (9CI)
|
65514-82-1
|
C8H11ClO
|
|
3-Cyclohexene-1-carbonyl chloride, 1-(1-methylethyl)- (9CI)
|
65514-83-2
|
C10H15ClO
|
|
3-Cyclopentene-1-carbonyl chloride, 2,2,3-trimethyl- (9CI)
|
65514-84-3
|
C9H13ClO
|
|
alpha-[[[(2-aminophenyl)methyl]methylamino]methyl]benzyl alcohol
|
65514-97-8
|
C16H20N2O
|
|
3-Methoxy-6-Methyl-2-pyridinecarboxylic acid Methyl ester
|
65515-24-4
|
C9H11NO3
|
|
Methyl 2,6-dimethoxypyridine-3-carboxylate
|
65515-26-6
|
C9H11NO4
|
|
Methyl 2,6-dichloronicotinate
|
65515-28-8
|
C7H5Cl2NO2
|
|
3-Pyridinecarboxylic acid, 6-chloro-2-methoxy-, methyl ester
|
65515-32-4
|
C8H8ClNO3
|
|
6-chloro-2-methoxynicotinic acid
|
65515-33-5
|
C7H6ClNO3
|
|
2-METHOXY-4,6-DIMETHYLPYRIDINE-3-CARBOXYLIC ACID
|
65515-37-9
|
C9H11NO3
|
|
2-METHOXY-4,6-DIMETHYLNICOTINONITRILE
|
65515-39-1
|
C9H10N2O
|
|
benzyl anisate
|
65515-53-9
|
C15H14O3
|
|
2-Propanone, 1-imino-1-phenyl-, oxime
|
65516-14-5
|
C9H10N2O
|
|
1,2,3,4,5-Pentakis(methylthio)benzene
|
65516-74-7
|
C11H16S5
|
|
Metaclazepam
|
65517-27-3
|
C18H18BrClN2O
|
|
DL-Canaline dihydrochloride
|
65518-20-9
|
C4H12Cl2N2O3
|
|
tert-butyloxycarbonylvalyl-valyl-valyl-valyl-valyl-valyl-valyl-valine methyl ester
|
65519-02-0
|
C46H84N8O11
|
|
2,5-Piperazinedione,3-methyl-6-methylene-,(S)-(9CI)
|
65519-18-8
|
C6H8N2O2
|
|
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-methylene-, (S)- (9CI)
|
65519-42-8
|
C8H10N2O2
|
|
2-methyl-3-(2,4,5-trihydroxyphenyl)alanine
|
65520-36-7
|
C10H13NO5
|
|
bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] hydrogen glutarate
|
65520-42-5
|
C25H48O10
|
|
bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] succinate
|
65520-45-8
|
C24H46O10
|
|
bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] adipate
|
65520-46-9
|
C26H50O10
|
|
1,2:13,14-diepoxytetradecane
|
65520-48-1
|
C14H26O2
|
|
gamma-glutamyl tyramine
|
65520-56-1
|
C13H18N2O4
|
|
|
FACTOR V ACTIVATOR
|
65522-14-7
|
|
|
(Z)-2-Methyl-2-butenoic acid (1aR,1bS,2aS,4S,4aS,7aR,8S,9aR)-dodecahydro-4-hydroxy-9a-methyl-3,7-bis(methylene)-6-oxobisoxireno[5,6:7,8]cyclodeca[1,2-b]furan-8-yl ester
|
65522-32-9
|
C20H24O7
|
|
Punctaporonin E
|
65522-91-0
|
C15H24O3
|
|
4,9-diazabicyclo[4.3.0]nona-7,10-diene-3,5-dione
|
65523-03-7
|
C7H6N2O2
|
|
diethyl 2-cyano-3-imino-pentanedioate
|
65523-05-9
|
C10H14N2O4
|
|
Benzenesulfonamide, 4-methyl-N-3-pyridinyl-
|
65523-65-1
|
C12H12N2O2S
|
|
1-Propanone, 2-chloro-1-(2-naphthalenyl)- (9CI)
|
65523-99-1
|
C13H11ClO
|
|
3-(3,4-Dihydroxyphenyl)propenoic acid 2-acetoxy-3-[[3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]propyl ester
|
65526-89-8
|
C23H22O9
|
|
Bis[3-(3,4-dihydroxyphenyl)propenoic acid]2-acetoxy-1,3-propanediyl ester
|
65526-90-1
|
C23H22O10
|
|
(20S)-3β-Hydroxylupan-29-oic acid
|
65527-05-1
|
C30H50O3
|
|
(24E)-3α,5-Cyclo-5α-stigmast-24(28)-en-6β-ol
|
65527-12-0
|
C29H48O
|
|
(24Z)-3α,5-Cyclo-5α-stigmast-24(28)-en-6β-ol
|
65527-16-4
|
C29H48O
|
|
(22E,24R)-6β-Chloro-5α-stigmast-22-ene-3β,5-diol
|
65527-21-1
|
C29H49ClO2
|
|
(22E,24R)-3β-Acetyloxy-6β-chloro-5α-stigmast-22-en-5-ol
|
65527-22-2
|
C31H51ClO3
|
|
(22E,24R)-3β-Methoxystigmasta-5,22-dien-4β-ol
|
65527-26-6
|
C30H50O2
|
|
(1R)-7β-(4-Hydroxy-3-methoxyphenyl)-3-methoxy-6α-methyl-5β-allylbicyclo[3.2.1]oct-3-ene-2,8-dione
|
65527-31-3
|
C20H22O5
|
|
8-Hydroxy-1,2-dimethoxy-7-(7-methoxy-1,3-benzodioxol-5-yl)-6-methyl-5-allylbicyclo[3.2.1]octan-3-one
|
65527-34-6
|
C22H28O7
|
|
(1S,8-syn)-3,8-Dihydroxy-7β-(7-methoxy-1,3-benzodioxol-5-yl)-6α-methyl-5α-allylbicyclo[3.2.1]oct-3-en-2-one
|
65527-36-8
|
C20H22O6
|
|
(1R,8-syn)-3,8-Dihydroxy-1-methoxy-7β-(7-methoxy-1,3-benzodioxol-5-yl)-6α-methyl-5α-allylbicyclo[3.2.1]oct-3-en-2-one
|
65527-37-9
|
C21H24O7
|
|
(1S,8-syn)-8-Hydroxy-3-methoxy-7β-(7-methoxy-1,3-benzodioxol-5-yl)-6α-methyl-5α-allylbicyclo[3.2.1]oct-3-en-2-one
|
65527-38-0
|
C21H24O6
|
|
(1R,8-syn)-8-Hydroxy-1,3-dimethoxy-7β-(7-methoxy-1,3-benzodioxol-5-yl)-6α-methyl-5α-allylbicyclo[3.2.1]oct-3-en-2-one
|
65527-39-1
|
C22H26O7
|
|
(1S)-3-Methoxy-7β-(7-methoxy-1,3-benzodioxol-5-yl)-6α-methyl-5α-allylbicyclo[3.2.1]oct-3-ene-2,8-dione
|
65527-40-4
|
C21H22O6
|
|
cefuroxime lysine
|
65527-51-7
|
|
|
(3R)-THIOMORPHOLINECARBOXYLIC ACID
|
65527-54-0
|
C5H9NO2S
|
|
AL-LAD
|
65527-61-9
|
C22H27N3O
|
|
N-Ethylnorlysergic Acid N,N-diethylaMide
|
65527-62-0
|
C21H27N3O
|
|
1-Oleoyl Lysophosphatidic Acid
|
65528-98-5
|
C21H41O7P
|
|
7,8,8-trimethyl-4,7-methano-2H-indazole
|
65529-87-5
|
C11H16N2
|
|
Methyl4,6-O-benzylidene-a-D-mannopyranoside
|
65530-26-9
|
C14H18O6
|
|
Methyl4,6-O-benzylidene-3-deoxy-a-D-glucopyranoside
|
65530-28-1
|
C14H18O5
|
|
2-Furfurylthio-3-methylpyrazine
|
65530-53-2
|
C10H10N2OS
|
|
|
Poly(difluoromethylene), α-fluoro-ω-[2- [[2-(trimethylammonio)ethyl]thio]ethyl]-, methyl sulfate
|
65530-57-6
|
CH3O4S.(CF2)nC7H17FNS
|
|
|
Poly(difluoromethylene), α-fluoro-ω-(2-hydroxyethyl)-, ester with 2,15-bis(carboxymethyl)-4, 13-dioxo-3,14-dioxa-5,12-diazahexadecane-1,2,15,16 -tetracarboxylic acid (6:1)
|
65530-58-7
|
(CF2)n(CF2)n(CF2)n(CF2)n(CF2)n(CF2)nC32H46F6N2O16
|